Thursday, March 31

[JS01] KAI-KSH Joint Session

Date & Time	March 31 (Thursday), 9:00-10:30	Room 1
Chairs	Kyungho Choi (Seoul National University College of Medicine, Korea) Seok-Goo Cho (The Catholic University of Korea, Korea)
Presentations	Next generation CAR-T cell therapy against hematological malignancies Kyungho Choi (Seoul National University College of Medicine, Korea) Effective conditioning regimen in adoptive T cell therapy of cancer Chungyong Han (National Cancer Center, Korea) Tissue resident memory T cells in multiple myeloma Yoon Seok Choi (Ajou University School of Medicine, Korea) T-cell-based immunotherapeutic strategies against EBV-positive malignancies using the novel TCR specific for LMP1 antigen Tai-Gyu Kim (The Catholic University of Korea, Korea)

[SS01] Scientific Session 01: Pediatric Disease

Date & Time	March 31 (Thursday), 9:00-10:30	Room 2
Chairs	Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea) Hyeon Jin Park (National Cancer Center, Korea)
Presentations	Primary immune regulatory disorder for the pediatric hematologist and oncologist Shanmuganathan Chandrakasan (Emory University School of Medicine, USA) Clonal evolution and somatic reversion in bone marrow failure Akiko Shimamura (Harvard Medical School, USA) Molecular landscape of pediatric AML Soheil Meshinchi (Fred Hutchinson Cancer Research Center, USA)

[SS02] Scientific Session 02: Lymphoma (1) - B cell / CLL

Date & Time	March 31 (Thursday), 9:00-10:30	Room 3
Chairs	Jae-Yong Kwak (Jeonbuk National University Medical School, Korea) Deok Hwan Yang (Chonnam National University Medical School, Korea)
Presentations	Molecular classification of diffuse large B-cell lymphoma and novel treatment strategies Daisuke Ennishi (Okayama University Hospital, Japan) Novel immunotherapeutic antibodies for B-cell NHL Gilles Salles (Memorial Sloan Kettering Cancer Center, USA) Targeting B-cell receptor and BCL-2 in chronic lymphocytic leukemia Susan M. O'Brien (University of California, USA)

[ES01] Education Session 01: Platelet Disorder

Date & Time	March 31 (Thursday), 9:00-10:30	Room 4
Chairs	Hyun Kyung Kim (Seoul National University College of Medicine, Korea) Sung Hwa Bae (Daegu Catholic University Hospital, Korea)
Presentations	Diagnostic work up of inherited platelet disorder Bohyun Kim (Soonchunhyang University College of Medicine, Korea) Recent advances in treatments of immune thrombocytopenia Dae Sik Kim (Korea University Guro Hospital, Korea) Thrombocytopenia in pregnancy Young Hoon Park (Ewha Womans University Mokdong Hospital, Korea)

[PL01] Plenary Lecture 01

Date & Time	March 31 (Thursday), 10:30-11:15	Room 1
Chair	Dong-Wook Kim (Uijeongbu Eulji Medical Center, Eulji University, Korea)
Presentation	Immune landscape of hematological malignancies and functional screening tools Satu Mustjoki (University of Helsinki, Finland)

[SY01] Satellite Symposium 01 (Sponsored by Handok)

Date & Time	March 31 (Thursday), 11:30-12:10	Room 1
Chair	Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Presentation	What is the role of C5 inhibitors in PNH? Jin Seok Kim (Yonsei University College of Medicine, Korea)

[SY02] Satellite Symposium 02 (Sponsored by Astellas)

Date & Time	March 31 (Thursday), 11:30-12:10	Room 2
Chair	Hyeoung-Joon Kim (Hwasun Chonnam National University Hospital, Korea)
Presentation	Gilteritinib: ADMIRAL study and real world experience Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea)

[SY03] Satellite Symposium 03 (Sponsored by Novartis)

Date & Time	March 31 (Thursday), 11:30-12:10	Room 3
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation	Role of CD19-directed CAR-T therapy in patients with DLBCL (Novartis Kymriah Symposium) Koji Izutsu (National Cancer Center Hospital, Japan)

[SY04] Satellite Symposium 04 (Sponsored by Janssen)

Date & Time	March 31 (Thursday), 11:30-12:10	Room 4
Chair	Chang-Ki Min (Seoul St. Mary's Hospital, The Catholic University of Korea, Korea)
Presentation	Immunotherapy in multiple myeloma Ajai Chari (Mount Sinai, USA)

[YI] Young Investigator Presentation

Date & Time	March 31 (Thursday), 12:40-13:40	Room 1
Chairs	Je-Hwan Lee (University of Ulsan College of Medicine, Korea) Deok Hwan Yang (Chonnam National University Medical School, Korea)
Presentations	Establishment of a preclinical model for acquired resistance to FMS-like tyrosine kinase 3 (FLT3) inhibitors and development of a basis for overcoming the resistance in FLT3 mutated acute myeloid leukemia Eun-Ji Choi (University of Ulsan College of Medicine, Korea) Identification of tyrosine kinase resistance mechanisms through next-generation sequencing analysis in chronic myeloid leukemia patients Saeam Shin (Yonsei University College of Medicine, Korea) Correlation between cytomorphological fi ndings and molecular genetic characteristics using digital imaging in patients with pre-myelodysplastic syndrome Chang-Hun Park (Samsung Changwon Hospital, Korea) Clinical implication of plasma-derived circulating tumor DNA (ctDNA) changes in patients with advanced diff use large B-cell lymphoma treated with immunochemotherapy Ga-Young Song (Chonnam National University Medical School, Korea) A cohort study to investigate the correlation between the microbiome and Diff use large B cell lymphoma (DLBCL) Sang Eun Yoon (Sungkyunkwan University School of Medicine, Korea) Analysis of marrow-infi ltrating T cell subpopulation in newly diagnosed multiple myeloma Myung-Won Lee (Chungnam National University College of Medicine, Korea) Multi-omics analysis of pediatric patients undergoing haploidentical hematopoietic stem cell transplantation with busulfun-based conditioning regimen and post-transplant cyclophosphamide Kyung Taek Hong (Seoul National University College of Medicine, Korea) Development of acute GVHD biomarkers in pediatric patients Sung Han Kang (Asan Medical Center, Korea)

[OP01] Oral Presentation 01: AML, MDS

Date & Time	March 31 (Thursday), 12:40-13:40	Room 2
Chairs	Byung-Soo Kim (Korea University College of Medicine, Korea) Dong-Yeop Shin (Seoul National University College of Medicine, Korea)
Presentations	Potential prognostic signifi cance of promoter methylation status of DNA repair genes at diagnosis in acute myeloid leukemia: analysis of TCGA-LAML cohort and patients in a single institution Sholhui Park (Ewha Womans University School of Medicine, Korea) TP53-mutated AML with high variant allele frequency show better survival outcome with hypomethylating agents than with cytarabine-based induction Hye Won Kook (Yonsei University College of Medicine, Korea) WT1 gene expression in primary acute myeloid leukemia Ishan Gupta (All India Institute of Medical Sciences, India) Preliminary results by age group of treatment with CPX-351 plus venetoclax in adults with newly diagnosed AML: subgroup analysis of the v-fast trial Vinod Pullarkat (City of Hope Comprehensive Cancer Center, USA) A randomized, phase II, comparative study with a parallel control for evaluating the efficacy and safety of 5-day azacitidine for patients with lower-risk MDS Silvia Park (The Catholic University of Korea, Korea)

[OP02] Oral Presentation 02: Lymphoma, Histiocytosis

Date & Time	March 31 (Thursday), 12:40-13:40	Room 3
Chairs	Ki-Seong Eom (College of Medicine, The Catholic University of Korea, Korea) Sukjoong Oh (Hanyang University Seoul Hospital, Korea)
Presentations	High incidence of MYD88 mutation associated with mutated IGHV gene in Korean chronic lymphocytic leukemias Ari Ahn (The Catholic University of Korea, Korea) First interim analysis results of ALPINE phase 3 study of zanubrutinib vs ibrutinib in R/R chronic lymphocytic leukemias/ small lymphocytic leukemias Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) CD 19 chimeric antigen receptor T cell therapy for relapsed/refractory B-cell lymphoid malignancies: the effi cacies and safeties of tisa-cel in the real world Sang Eun Yoon (Sungkyunkwan University School of Medicine, Korea) Long-term real-world experience of Castleman’s disease treatment Gi June Min (The Catholic University of Korea, Korea) Clinical analysis 0f modifi ed HLH-04 regimen for the treatment of childhood hemophagocytic lymphohistiocytosis Fenfen Cheng (Capital Medical University, China)

[OP03] Oral Presentation 03: Laboratory Hematology

Date & Time	March 31 (Thursday), 12:40-13:40	Room 4
Chairs	Myung-Hyun Nam (Korea University Anam Hospital, Korea) Young-Uk Cho (University of Ulsan College of Medicine, Korea)
Presentations	Clinical-biochemical screening and genetic analysis of suspected inherited iron meNGStabolism related anaemias using targeted ngs approach Pankaj Sharma (PGIMER, India) Comparison of clinical features, genetic alterations, and outcomes in patients with prefibrotic, overt primary myelofibrosis, and secondary myelofibrosis Tong Yoon Kim (The Catholic University of Korea, Korea) Flow cytometry of body fluid specimens: diagnostic value in hematologic malignancy Smeeta G (All India Institute of Medical Sciences, India) Single-cell analysis of Multiple Myelomas refines bortezomib treatment responsiveness Sung-Soo Park (The Catholic University of Korea, Korea) Empagliflozin modulates CD4+ T cell differentiation via metabolic reprogramming in immune thrombocytopenia Qin Jing (Shandong University, China)

[AS01] Asian Session I: AA

Date & Time	March 31 (Thursday), 13:55-14:55	Room 1
Chairs	Jong Wook Lee (Seoul St. Mary's Hospital, The Catholic University of Korea, Korea) Hoon Kook (Chonnam National University Medical School, Korea)
Presentations	Korean treatment guideline for aplastic anemia Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea) Aplastic anemia immunosuppressive therapy in China Zhao Xin (Institute of Hematology and Blood Diseases Hospital, China) Clinical significance of detecting HLA-class I allele-lacking leukocytes in patients with aplastic anemia Kohei Hosokawa (Kanazawa University, Japan)

[SS03] Scientific Session 03: MPN

Date & Time	March 31  (Thursday), 13:55-15:25	Room 2
Chairs	Chul Won Choi (Korea University Guro Hospital, Korea) Sung-Yong Kim (Konkuk University School of Medicinek, Korea)
Presentations	Recent advances in molecular diagnosis, prognosis and monitoring of MPNs Myungshin Kim (The Catholic University of Korea, Korea) Molecular mechanisms underlying the development of MPN by mutant calreticulin and the therapeutic potential of an antibody targeting mutant calreticulin Norio Komatsu (Juntendo University Graduate School of Medicine, Japan) Targeting pro-inflammatory signaling, including IL8, in myelofibrosis: the pathway into the clinic Andrew J. Dunbar (Memorial Sloan Kettering Cancer Center, USA)

[SS04] Scientific Session 04: MM

Date & Time	March 31 (Thursday), 13:55-15:25	Room 3
Chairs	Dong Soon Lee (Seoul National University College of Medicine, Korea) Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Presentations	Evolution of myeloma from the normal plasma cell to disease complexity Niccolo Bolli  (University of Milan, Italy) The power of ONE: immunology in the age of single cell genomics Ido Amit  (Weizmann Institute, Israel) Clinical implication of immune network in multiple myeloma Je-Jung Lee, (Chonnam National University Medical School, Korea)

[ES02] Education Session 02: AML

Date & Time	March 31 (Thursday), 13:55-15:25	Room 4
Chairs	Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea) Dong-Yeop Shin (Seoul National University College of Medicine, Korea)
Presentations	Human AML stem cell: evolution of concept Dong-Yeop Shin (Seoul National University Hospital, Korea) Recent update of AML risk stratification Hyoeun Shim (National Cancer Center, Korea) FLT3 mutated AML Jae-Sook Ahn (Chonnam National University Medical School, Korea)

[JS02] KOGO-KSH Joint Session

Date & Time	March 31 (Thursday), 15:40~17:10	Room 1
Chairs	Hae-Ock Lee (The Catholic University of Korea, Korea) Sun-Young Kong (National Cancer Center, Korea)
Presentations	Developing single-cell data integration pipeline to find novel cell types and gene markers for immune diseases Jong-Eun Park (Korea Advanced Institute of Science and Technology, Korea) Detection of enhancer hijacking of oncogenes in multiple myeloma Jin-Wu Nam (Hanyang University, Korea) Pharmacogenetics of childhood acute lymphoblastic leukemia Hyery Kim (University of Ulsan College of Medicine, Korea) Evaluating leukemic structural variations using optical genome mapping Saeam Shin (Yonsei University College of Medicine, Korea)

[SS05] Scientific Session 05: CML

Date & Time	March 31 (Thursday), 15:40~17:10	Room 2
Chairs	Chul Won Jung (Sungkyunkwan University School of Medicine, Korea) Won Sik Lee (Inje University College of Medicine, Korea)
Presentations	Resistance mechanism in CML Kimmo Porkka (Helsinki University Central Hospital, Finland) Mutational landscape in CML Simona Soverini (University of Bologna, Italy) CML/MPN stem cells and the bone marrow microenvironment Steffen Koschmieder (RWTH Aachen University, Germany)

[SS06] Scientific Session 06: Cell Therapy / Transplantation

Date & Time	March 31 (Thursday), 15:40~17:10	Room 3
Chairs	Hyeon-Seok Eom (National Cancer Center, Korea) Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Presentations	Immune landscapes and chemotherapy resistance in AML Sergio Rutella (Nottingham Trent University, UK) Towards next-generation T cell engineering for cancer Chan Hyuk Kim (Korea Advanced Institute of Science and Technology, Korea) Endogenous retroviruses as a source of tumor antigens in solid tumors and acute myeloid leukemia Stéphane Depil (Université Claude Bernard Lyon 1, France)

[ES03] Education Session 03: Thrombosis/ Hemostasis

Date & Time	March 31 (Thursday), 15:40~17:10	Room 4
Chairs	Sung-Hyun Kim (Dong-A University College of Medicine, Korea) Jin-Yeong Han (Dong-A University College of Medicine, Korea)
Presentations	Advances in laboratory assessment in thrombosis/hemostasis Jaewoo Song (Yonsei University College of Medicine, Korea) Cancer-associated thrombosis Ho-Young Yhim (Jeonbuk National University Medical School, Korea) Recent advances in the management of immune mediated TTP Sung Hwa Bae (Daegu Catholic University Hospital, Korea)

Friday, April 1

[JS03] ASH-KSH Joint Symposium: Histiocytosis

Date & Time	April 1 (Friday), 9:00-10:30	Room 1
Chairs	Jane Winter (Feinberg School of Medicine, USA) Ho Joon Im (University of Ulsan College of Medicine, Korea)
Presentations	Biologic and clinical consequences of the BRAFV600E mutation in langerhans cell histiocytosis Kenneth McClain (Texas Children's Cancer Center, USA) Advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis Kim E. Nichols (St. Jude Children's Research Hospital, USA) Current status of diagnosis and treatment of Langerhans cell histiocytosis in Korea Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) Adult hemophagocytic lymphohistiocytosis in Korea Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)

[SS07] Scientific Session 07: Stem Cell Biology

Date & Time	April 1 (Friday), 9:00-10:30	Room 2
Chairs	Myung Geun Shin (Chonnam National University Medical School, Korea) June-Won Cheong (Yonsei University College of Medicine, Korea)
Presentations	Losing sense of self and surroundings: hematopoietic stem cell aging and leukemic transformation Emmanuelle Passegue (Columbia University Irving Medical Center, USA) Hematopoietic stem and progenitor cell signaling in the niche Peter Kurre (Children's Hospital of Philadelphia, USA) Thrombopoietin as an expansion factor for hematopoietic stem cells Toshio Suda (Kumamoto University, Japan)

[SS08] Scientific Session 08: Thrombosis & Hemostasis

Date & Time	April 1 (Friday), 9:00-10:30	Room 3
Chairs	Soo-Mee Bang (Seoul National University College of Medicine, Korea) Seongsoo Jang (University of Ulsan College of Medicine, Korea)
Presentations	Mechanism of thrombosis and bleeding in viral infection: focusing on COVID-19 Marcel Levi (University College London Hospitals NHS Foundation Trust, UK) COVID-19 vaccine related hematologic manifestations Soo-Mee Bang (Seoul National University Bundang Hospital, Seoul National University College of Medicine, Korea) Thrombotic thrombocytopenic purpura in 2022 - novel therapies and focus on long term outcomes Shruti Chaturvedi (Johns Hopkins University School of Medicine, USA)

[ES04] Education Session 04: Plasma Cell Disorder

Date & Time	April 1 (Friday), 9:00-10:30	Room 4
Chairs	Je-Jung Lee (Chonnam National University Medical School, Korea) Dok Hyun Yoon (Asan Medical Center, University of Ulsan College of Medicine, Korea)
Presentations	Diagnosis and management of monoclonal gammopathy of clinical significance Hyungwoo Cho (University of Ulsan College of Medicine , Korea) Update in the POEMS syndrome Yu Ri Kim (Yonsei University College of Medicine, Korea) Update in the primary plasma cell leukemia Sung-Hoon Jung (Chonnam National University Hwasun Hospital, Korea)

[PL02] Plenary Lecture 02

Date & Time	April 1 (Friday), 10:30-11:15	Room 1
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation	Rational development of targeted therapies to cure molecular subtypes of DLBCL Louis M. Staudt (National Cancer Institute, USA)

[SY05] Satellite Symposium 05 (Sponsored by Kyowa Kirin)

Date & Time	April 1 (Friday), 11:30-12:10	Room 1
Chair	Jong Wook Lee (Seoul St. Mary's Hospital, The Catholic University of Korea, Korea)
Presentation	Role of romiplostim in ITP and AA Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)

[SY06] Satellite Symposium 06 (Sponsored by Otsuka)

Date & Time	April 1 (Friday), 11:30-12:10	Room 2
Chair	Dong-Wook Kim (Uijeongbu Eulji Medical Center, Eulji University, Korea)
Presentation	The updated information of ponatinib use in chronic myeloid leukemia Jorge E. Cortes (Georgia Cancer Center, USA)

[SY07] Satellite Symposium 07 (Sponsored by Roche)

Date & Time	April 1 (Friday), 11:30-12:10	Room 3
Chair	Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	Strategic treatment for diffuse large B-Cell lymphoma; incorporating polatuzumab to DLBCL Christopher Flowers (The University of Texas MD Anderson Cancer Center, USA)

[SY08] Satellite Symposium 08 (Sponsored by BMS-Celgene)

Date & Time	April 1 (Friday), 11:30-12:10	Room 4
Chair	Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	Optimal treatment with IMiDs in newly diagnosed multiple myeloma Luciano J. Costa (The University of Alabama at Birmingham, USA)

[OP04] Oral Presentation 04: ALL

Date & Time	April 1 (Friday), 12:40-13:40	Room 1
Chairs	Inho Kim (Seoul National University Hospital, Korea) Kyung-Nam Koh (University of Ulsan College of Medicine, Korea)
Presentations	Expression pattern of non-homologous end joining DNA repair pathway genes and its clinical relevance in T-lineage acute lymphoblastic leukemia Anita Chopra (All India Institute of Medical Sciences, India) Interim analysis of the prospective phase II study of individualized 6-mercaptopurine dosing based on pharmacogenomics in childhood acute lymphoblastic leukemia Hyery Kim (University of Ulsan College of Medicine, Korea) Current treatment trends of infant Leukemia in Korea based on a retrospective multicenter reivew: the Korean society of hematology, pediatric all working group Seung Min Hahn (Yonsei Cancer Center, Korea) Prognostic impact of cytogenetic classifi cation in adult all patients treated with intensive chemotherapy and allogeneic HCT-based post-remission therapy Jae-Ho Yoon (The Catholic University of Korea, Korea) Defi france registry study: effi cacy and safety of defi brotide for the treatment of severe/very severe vod/sos after hematopoietic cell transplantation Mohamad Mohty (Hôpital St Antoine, Sorbonne University, France)

[OP05] Oral Presentation 05: Anemia, BMF, CML, MPN

Date & Time	April 1 (Friday), 12:40-13:40	Room 2
Chairs	Hawk Kim (Gachon University College of Medicine, Korea) Sung-Eun Lee (The Catholic University of Korea, Korea)
Presentations	Causal role of iron status on anemia and on cardiometabolic outcomes among UK whites and Taiwanese Han Chinese using hemoglobin-genetic risk scores Vanessa Joy Timoteo (National Yang Ming Chiao Tung University and Academia Sinica, Taiwan) Favorable outcomes of familial-mismatched donor transplantation using post-transplant cylophosphamide(PTCy) for pediatric severe aplastic anemia Jae Won Yoo (The Catholic University of Korea, Korea) The long-term effi cacy and safety of eculizumab in patients with paroxysmal nocturnal hemoglobinuria; retrospective study on behalf of Korean society of hematology aplastic anemia working party Jin Seok Kim (Yonsei University College of Medicine, Korea) Response to chemotherapy in patients with juvenile Myelomonocytic Leukemia in Korea: The Korean pediatric hematology-oncology group(KPHOG) Eun Sang Yi (Korea University College of Medicine, Korea) A multicenter, open-label, phase IV clinical study for effi cacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment Ja Min Byun (Seoul National University Hospital, Korea)

[OP06] Oral Presentation 06: MM

Date & Time	April 1 (Friday), 12:40-13:40	Room 3
Chairs	Jeong Yeal Ahn (Gachon University Gil Medical Center, Korea) Min Kyoung Kim (Yeungnam University Medical Center, Korea)
Presentations	Prognostic role of the ratio of natural killer to regulatory T cells in multiple myeloma treating lenalidomide and dexamethasone Seung Yeon Kim (The Catholic University of Korea, Korea) Rejuvenation of antigen-specific CD8+ T cells using induced pluripotent stem cell technology and specific regulatory pathways for T cell commitment Jooeun Bae (Harvard Medical School, USA) Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in multiple myeloma: KMMWP-1801 study Ga-Young Song (Chonnam National University Medical School, Korea) Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study Jongheon Jung (National Cancer Center, Korea) Subcutaneous daratumumab with bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed light chain (AL) amyloidosis: 18-month analysis of the phase 3 andromeda study Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)

[OP07] Oral Presentation 07: Platelet, Transfusion

Date & Time	April 1 (Friday), 12:40-13:40	Room 4
Chairs	Eun Sun Yoo (Ewha Womans University Seoul Hospital, Korea) Jaewoo Song (Yonsei University College of Medicine, Korea)
Presentations	2021 operation of the surveillance system of covid-19 vaccination induced thrombosis with thrombocytopenia syndrome in Korea Daehyun Chu (University of Ulsan College of Medicine, Korea) Validation of khorana score in cancer patients undergoing chemotherapy with east asian ethnicity Junshik Hong (Seoul National Universityi College of Medicine, Korea) Acute transfusion reactions of pediatric blood transfusions at Chiang Mai university hospital Pattira Rungruansarn (Chiang Mai University, Thailand) Risk factors of platelet transfusion refractoriness in patients with AA/MDS who receive allogeneic hematopoietic stem cell transplantation Jaeik Oh (Seoul National University Hospital, Korea) Combining pharmacokinetics and comprehensive evaluation system to individualize the prophylaxis in pediatric patients with hemophilia A Kun Huang (Capital Medical University, China)

[PS01] Presidential Lecture

Date & Time	April 2 (Friday), 13:55-14:40	Room 1
Chair	Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Presentation	Toward precision medicine in AML Hartmut Döhner (University of Ulm, Germany)

[MS01] MOU Country Session 01

Date & Time	April 1 (Friday), 14:40-15:40	Room 1
Chairs	Jae Hoon Lee (Gachon University Gil Medical Center, Korea) Jin Seok Kim (Yonsei University College of Medicine, Korea)
Presentations	Managing multiple myeloma in a resource-limited region: diagnosis and treatment in Armenia Yervand K. Hakobyan (Armenian Hematology Association, Armenia) Renal involvement in plasma cell disorder: learning from real-life practice Suporn Chuncharunee (Ramathibodi hospital, Thailand) Treatment sequence decision in multiple myeloma considering reimbursement status Youngil Koh (Seoul National University Hospital, Korea)

[SS09] Scientific Session 09: MDS

Date & Time	April 1 (Friday), 14:40-16:10	Room 2
Chairs	Yoo-Jin Kim (College of Medicine, The Catholic University of Korea, Korea) Yoon Hwan Chang (Seoul National University Hospital, Korea)
Presentations	Pathophysiology of spliceosome mutations in MDS Andrea Pellagatti (University of Oxford, UK) Role of extracellular vesicles and miRNA in myelodysplastic syndromes Sophie Park (CHU de Grenoble Service hematologie clinique, France) Challenges in the diagnosis and treatment of overlap MDS/MPN syndromes Antonio Almeida (Hospital da Luz Lisboa, Portugal)

[SS10] Scientific Session 10: ALL

Date & Time	April 1 (Friday), 14:40-16:10	Room 3
Chairs	Nack-Gyun Chung (The Catholic University of Korea, Korea) Ho-Jin Shin (Pusan National University School of Medicine, Korea)
Presentations	Chemotherapy vs. allogeneic HSCT for Ph–negative adult ALL Josep-Maria Ribera (ICO-Hospital Germans Trias i Pujol, Spain) Clonal heterogeneity in ALL Jan Cools (Center for Human Genetics, Belgium) Adoptive cellular immunotherapies based on chimeric antigen receptors Pablo Menendez (Josep Carreras Leukemia Research Institute, Spain)

[ES05] Education Session 05: AA and BMF

Date & Time	April 1 (Friday), 14:40-16:10	Room 4
Chairs	Myungshin Kim (The Catholic University of Korea, Korea) Yeung-Chul Mun (Ewha Womans University College of Medicine, Korea)
Presentations	Genetics and genomics of bone marrow failure syndrome Hyun-Young Kim (Sungkyunkwan University School of Medicine, Korea) Aplastic anemia: transplant vs non-transplant options Ik-Chan Song (Chungnam National University Hospital, Korea) Overview of bone marrow failure syndrome Meerim Park (National Cancer Center, Korea)

[JS04] EHA-KSH Joint Symposium: CML

Date & Time	April 1 (Friday), 16:25-17:55	Room 1
Chairs	Kirsten Grønbæk (University of Copenhagen, Denmark) Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea)
Presentations	Failing a second-generation TKI: when the guidelines don’t always help Jane Apperley (Imperial College London, UK) Discontinuation of tyrosine kinase inhibitors in CML patients in clinical practice Antonio Almeida (Hospital da Luz Lisboa, Portugal) Second and later line therapy : the role of ponatinib in Korean patients with CML Jeong-Ok Lee (Seoul National University Bundang Hospital, Korea) Stopping tyrosine kinase inhibitor in CML; perspectives from Korean data Hawk Kim (Gachon University College of Medicine, Korea)

[SS11] Scientific Session 11: Adv Technology

Date & Time	April 1 (Friday), 16:25-17:55	Room 2
Chairs	Duck Cho (Sungkyunkwan University School of Medicine, Korea) Ji-Myung Kim (Chungnam National University Hospitalm, Korea)
Presentations	Hematopoiesis and leukemia through the lens of single cell genomics Lars Velten (Centre for Genomic Regulation, Spain) Computer vision in hematologic malignancies Oscar Brück (University of Helsinki, Finland) Hydrogel-based stamping technology for solution-free blood cell staining Dongyoung Lee (Noul Co., Ltd, Korea)

[SS12] Scientific Session 12: Benign Hematology

Date & Time	April 1 (Friday), 16:25-17:55	Room 3
Chairs	Deog-Yeon Jo (Chungnam National University College of Medicine, Korea) Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
Presentations	The iron-erythropoiesis cross-talk in health and disease Antonella Nai (San Raffaele Scientific Institute, Italy) Autoimmune hemolytic anemia : state-of-the-art hypotheses on pathogenesis and their application to treatment Bruno Fattizzo (Università degli Studi di Milano, Italy) Cold agglutinin disease: an update on pathogenesis and future prospects on therapy Sigbjørn Berentsen (Haugesund Hospital, Norway)

[ES06] Education Session 06: Lymphoma

Date & Time	April 1 (Friday), 16:25-17:55	Room 4
Chairs	Jong Ho Won (Soonchunhyang University College of Medicine, Korea) Young Rok Do (Keimyung University School of Medicine, Korea)
Presentations	Lymphoma pathology: basic immunohistochemistry for lymphoma diagnosis Junhun Cho (Sungkyunkwan University School of Medicine, Korea) Staging and response assessment of lymphoma Kwai Han Yoo (Gachon University Gil Medical Center, Korea) Treatment of indolent lymphoma Seong Hyun Jeong (Ajou University School of Medicine, Korea)

Saturday, April 2

[AS02] Asian Session II: Pediatric ALL

Date & Time	April 2 (Saturday), 09:00-10:00	Room 1
Chairs	Chuhl Joo Lyu (Yonsei University Health System, Korea) Keon Hee Yoo (Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea)
Presentations	Ma-Spore ALL studies: truly Asia approach to curing childhood ALL Allen E.J. Yeoh (National University of Singapore, Singapore) Childhood ALL in Thailand and multicenter studies of Thai pediatric oncology group Samart Pakakasama (Mahidol University, Thailand) The adherence to MRD time points improves treatment outcomes of childhood ALL in Taiwan: the experience of TPOG-ALL-2013 protocol Hsi-Che Liu (Mackay Memorial Hospital, Taiwan)

[SS13] Scientific Session 13: AML

Date & Time	April 2 (Saturday), 09:00-10:30	Room 2
Chairs	Hee-Je Kim (The Catholic University of Korea, Korea) Young Kyung Lee (Hallym University College of Medicine, Korea)
Presentations	AML microenvironment and FLT3 inhibitor resistance Elie Traer (Oregon Health & Science University, USA) Targeting TP53 mutation in AML David A. Sallman (H. Lee Moffitt Cancer Center and Research Institute, USA) Adaptive immune resistance and immune evasion by programmed death-1 homolog (PD-1H/VISTA) in AML Tae Kon Kim (Vanderbilt University Medical Center, USA)

[SS14] Scientific Session 14: Lymphoma (2) - T cell / HL

Date & Time	April 2 (Saturday), 09:00-10:30	Room 3
Chairs	Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) Ho-Young Yhim (Jeonbuk National University Hospital, Korea)
Presentations	Genomic landscape of peripheral T-cell lymphomas Keisuke Kataoka (National Cancer Center Research Institute, Japan) T-cell lymphomas of follicular helper T-cell derivation: pathology, mechanisms and therapeutic implications Laurence de Level (Lausanne University Hospital, Switzerland) Targeted therapy to small molecules in peripheral T cell lymphomas Deok Hwan Yang (Chonnam National University Medical School, Korea)

[ES07] Education Session 07: Supportive Care

Date & Time	April 2 (Saturday), 09:00-10:30	Room 4
Chairs	Seong Kyu Park (Soonchunhyang University Bucheon Hospital, Korea) Hyo Jung Kim (Hallym University College of Medicine, Korea)
Presentations	Comprehensive geriatric assessment in older patients for intensive chemotherapy Jung-Yeon Choi (Seoul National University Bundang Hospital, Korea) Evaluation and management of platelet transfusion refractoriness Dae-Hyun Ko (University of Ulsan College of Medicine, Korea) Advances in management of invasive fungal infections: perspectives on hematologic diseases Dong-Gun Lee (Seoul St. Mary's Hospital, The Catholic University of Korea, Korea)

[PL03] Plenary Lecture 03

Date & Time	April 2 (Saturday), 10:30-11:15	Room 1
Chair	Chuhl Joo Lyu (Yonsei University Health System, Korea)
Presentation	Improving outcomes after CD19-targeted CAR T-cell therapy Jordan Gauthier (University of Washington, USA)